https://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/AbbVie-European-Commission-Approves-RINVOQ-upadacitinib-for-the-Treatment-of-Adults-With-Moderat-41101914/?utm_source=telegram&utm_medium=social&utm_campaign=share